Azienda Ospedaliera Universitaria "Federico II"

Naples, Via Pansini 80131

0 studies enrolling now · 2 studies all time

What they study most

Fabry Disease

Studies at this site

• Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients — Completed
• Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease — Completed